304 related articles for article (PubMed ID: 16620269)
1. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
[TBL] [Abstract][Full Text] [Related]
3. The role of non-alcoholic fatty liver disease in cardiovascular disease.
Perseghin G
Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.
Targher G
Diabet Med; 2007 Jan; 24(1):1-6. PubMed ID: 17227317
[TBL] [Abstract][Full Text] [Related]
6. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
8. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
Fan JG
J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
[TBL] [Abstract][Full Text] [Related]
9. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
Stern MP; Williams K; Hunt KJ
Atheroscler Suppl; 2005 May; 6(2):3-6. PubMed ID: 15823490
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
[TBL] [Abstract][Full Text] [Related]
12. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
Mohan V; Farooq S; Deepa M; Ravikumar R; Pitchumoni CS
Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251
[TBL] [Abstract][Full Text] [Related]
14. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
Ong JP; Pitts A; Younossi ZM
J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
[TBL] [Abstract][Full Text] [Related]
15. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
16. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
Picardi A; Vespasiani-Gentilucci U
Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
[TBL] [Abstract][Full Text] [Related]
19. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]